MedPath

ASAN FOUNDATION

ASAN FOUNDATION logo
🇰🇷South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Phase 2
Recruiting
Conditions
Liver Cancer
Hepatocellular Carcinoma Stage IV
Hepatocellular Carcinoma
Hepatocellular Cancer
Hepatocellular Carcinoma Non-resectable
Interventions
Radiation: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
First Posted Date
2023-08-15
Last Posted Date
2025-02-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
138
Registration Number
NCT05992220
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

AVIAR(MX-02) Robotic-assisted Percutaneous Coronary Intervention

Completed
Conditions
Percutaneous Coronary Intervention
First Posted Date
2023-08-08
Last Posted Date
2024-07-17
Lead Sponsor
Asan Medical Center
Target Recruit Count
21
Registration Number
NCT05981859
Locations
🇰🇷

The Catholic University of Korea Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Textbook and Survival Outcomes of MIPD in South Korea

Completed
Conditions
Surgery-Complications
First Posted Date
2023-08-04
Last Posted Date
2023-08-04
Lead Sponsor
Asan Medical Center
Target Recruit Count
1552
Registration Number
NCT05975710
Locations
🇰🇷

Asan medical center, Seoul, Korea, Republic of

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Phase 2
Completed
Conditions
Carcinoma, Lobular
Interventions
Drug: [18F]fluoroestradiol (FES)
First Posted Date
2023-07-25
Last Posted Date
2024-08-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
23
Registration Number
NCT05960201
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma

Terminated
Conditions
Pheochromocytoma
Paraganglioma
Interventions
Diagnostic Test: F-18 FDOPA PET/CT
First Posted Date
2023-07-17
Last Posted Date
2023-07-17
Lead Sponsor
Asan Medical Center
Target Recruit Count
32
Registration Number
NCT05948137
Locations
🇰🇷

Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

Recruiting
Conditions
Endometrial Cancer
Peritoneal Cancer
Ovarian Cancer
Fallopian Tube Cancer
Cervical Cancer
Interventions
Other: Patient registry
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Asan Medical Center
Target Recruit Count
13500
Registration Number
NCT05912972
Locations
🇰🇷

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of

Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

Phase 2
Recruiting
Conditions
Gastrointestinal Stromal Tumors
Interventions
First Posted Date
2023-06-15
Last Posted Date
2024-02-28
Lead Sponsor
Asan Medical Center
Target Recruit Count
48
Registration Number
NCT05905887
Locations
🇰🇷

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer

Phase 2
Recruiting
Conditions
Solid Tumors
Advanced Solid Tumors
Metastatic Cancer
Interventions
First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Asan Medical Center
Target Recruit Count
32
Registration Number
NCT05904457
Locations
🇰🇷

Cha University Bundang Medical Center, Seongnam, Gyeonggi-do, Korea, Republic of

🇰🇷

Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of

🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

and more 7 locations

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Completed
Conditions
Postoperative Complications
Interventions
Procedure: surgery after neoadjuvant chemotherapy
First Posted Date
2023-06-05
Last Posted Date
2023-06-05
Lead Sponsor
Asan Medical Center
Target Recruit Count
1
Registration Number
NCT05888129
Locations
🇰🇷

Asan medical center, Seoul, Korea, Republic of

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Recruiting
Conditions
Brain Metastases
Radiosurgery
Interventions
Diagnostic Test: Magnetic resonance imaging (MRI)
Diagnostic Test: Diffusion-weighted MRI
Diagnostic Test: Arterial spin labeling (ASL)
Diagnostic Test: Dynamic susceptibility contrast-MRI (DSC-MRI)
First Posted Date
2023-05-22
Last Posted Date
2024-05-14
Lead Sponsor
Asan Medical Center
Target Recruit Count
132
Registration Number
NCT05868928
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath